Phenotype Guided Vasoactive Medication During Kidney Transplantation

Starting soon · Phase 4

Conditions studied: Kidney Transplant, Fluid Management

In brief

The goal of this clinical trial is to learn if vasopressin improves the body's response to intravenous fluids during kidney transplantation in patients who have relaxed blood vessels. Researchers will compare the results of vasopressin to those who received calcium chloride.

Key facts

Study ID

NCT07633600

Run by

Jennifer Cutler

People needed

255

Starts

2026-06-01

Expected to finish

2027-12-01

Last updated by the study team

2026-06-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged 18 years or older
• Undergoing kidney transplantation at Cedars-Sinai Medical Center
• Able to provide informed consent

You may not qualify if…

• Patients unable to provide informed consent
• Patients with contraindications to protocol vasoactive medications, as determined by the treating anesthesiologist
• Patients in whom required intraoperative monitoring cannot be performed

Where it is running

• Cedars Sinai Medical Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.